Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome

2020120 citationsJournal Articlebronze Open Access

Authors

These findings suggest that continued ACEi/ARB use in hypertensive COVID-19 patients yields better clinical outcomes.

Good health and well-being

Published in: The Journal of Infectious Diseases

Volume 222, Issue 8, pp. 1256-1264

Field-Weighted Citation Impact: 2.71